Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1998-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1998/831425 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841524597454798848 |
---|---|
author | George G Zhanel Andrew E Simor Lavern Vercaigne Lionell Mandell the Canadian Carbapenem Discussion Group |
author_facet | George G Zhanel Andrew E Simor Lavern Vercaigne Lionell Mandell the Canadian Carbapenem Discussion Group |
author_sort | George G Zhanel |
collection | DOAJ |
description | OBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects. |
format | Article |
id | doaj-art-05271c1cb6f742008391b2c991973ab2 |
institution | Kabale University |
issn | 1180-2332 |
language | English |
publishDate | 1998-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Infectious Diseases |
spelling | doaj-art-05271c1cb6f742008391b2c991973ab22025-02-03T05:47:50ZengWileyCanadian Journal of Infectious Diseases1180-23321998-01-019421522810.1155/1998/831425Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse EffectsGeorge G Zhanel0Andrew E Simor1Lavern Vercaigne2Lionell Mandell3the Canadian Carbapenem Discussion GroupDepartments of Medicine and Microbiology, Health Sciences Centre and Faculties of Pharmacy and Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, CanadaDepartment of Pharmacy, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Infectious Diseases, McMaster University, Hamilton, Ontario, CanadaOBJECTIVE: To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.http://dx.doi.org/10.1155/1998/831425 |
spellingShingle | George G Zhanel Andrew E Simor Lavern Vercaigne Lionell Mandell the Canadian Carbapenem Discussion Group Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects Canadian Journal of Infectious Diseases |
title | Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects |
title_full | Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects |
title_fullStr | Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects |
title_full_unstemmed | Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects |
title_short | Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects |
title_sort | imipenem and meropenem comparison of in vitro activity pharmacokinetics clinical trials and adverse effects |
url | http://dx.doi.org/10.1155/1998/831425 |
work_keys_str_mv | AT georgegzhanel imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects AT andrewesimor imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects AT lavernvercaigne imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects AT lionellmandell imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects AT thecanadiancarbapenemdiscussiongroup imipenemandmeropenemcomparisonofinvitroactivitypharmacokineticsclinicaltrialsandadverseeffects |